Prospective evaluation of the factors in geriatric assessment for predicting the vulnerability of the elderly patients in out-patient chemotherapy

Prospective evaluation of the factors in geriatric assessment for predicting the vulnerability of the elderly patients in out-patient chemotherapy - Prospective evaluation of the factors in geriatric assessment for predicting the vulnerability of the elderly patients in out-patient chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024395

Enrollment

100

Registered

2016-11-01

Start date

2016-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly cancer patients with solid tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) with 70 years of age or older (2) with a histologically confirmed diagnosis of cancer at any stage (3) those planing to continue chemotherapy more than 3 months (4) those fluent in Japanese

Exclusion criteria

Exclusion criteria: (1) with disturbance of consciousness (2) with severe physical impairment (3) with severe mental disorder (4) with hematologic malignancy (4) those considered inappropriate for the participation

Design outcomes

Primary

Measure	Time frame
To investigate which tools for ADL assessent (MOS-ADL, KPS, G8, or VES-13) could best predict the tolerability of the out-patient chemotherapy	—

Secondary

Measure	Time frame
To investigate the tolerability of the chemotherapy regimens selected by physician's subjective evaluation and CGA components independently associated with the tolerability.	—

Countries

Japan

Contacts

Public ContactAyumu Matsuoka

Nagoya University Hospital Clinical Oncology and Chemotherapy

ayumu0611@med.nagoya-u.ac.jp052-741-1903

Outcome results